David Penson
Professor and Chair · Vanderbilt University Medical Center
Credentials: · · · · · ·
History
PresentDepartment of Urologic Surgery · Duke University Hospital
- Present
Department of Urology · Vanderbilt University Medical Center
2001–2002
1998–2001- 1991–1998
Management in Health Care
- 1992–1997
UCLA Health System
- 1992–1993
UCLA Health System
1987–1991
Research
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
New England Journal of Medicine · 2010 · 4,436 citations
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 1,050 citations
Early detection of prostate cancer: AUA Guideline
The Journal of Urology · 2013 · 859 citations
90 papers
49 papers · 17 as a fellow
40 papers
39 papers · 1 as a resident
37 papers
32 papers
27 papers
26 papers · 22 as a resident
Grants
- 2022–2026
Randomized Trial of Empiric Versus Selective Preventative Strategies for Kidney Stone Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $325.8K · Vanderbilt University Medical Center
- 2014–2020
The Vanderbilt PCOR Career Knowledge, Education and Training Program
Agency for Healthcare Research and Quality · K12
Contact PI · $3.3M · Vanderbilt University Medical Center
- 2013–2019
PROMISS - Prostate Modeling to Identify Surveillance Strategies
National Cancer Institute · R01
PI · $2.9M · Fred Hutchinson Cancer Research Center
- 2013–2018
Comparative Effectiveness of Modern Therapies for Localized Prostate Cancer
Agency for Healthcare Research and Quality · R01
Contact PI · $1.8M · Vanderbilt University Medical Center
Clinical trials
- 2016–2020
Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
Principal investigator · Terminated
Chronix Biomedical Corporation
- 2011–2018
Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer
Principal investigator · Completed
Vanderbilt University